Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study)

Michael Feher   ^{1 *} , MD ;   William Hinton   ^{1 *} , MSc ;   Anna Forbes   ¹ , MBChB ;   Neil Munro   ^{2 *} , DPhil ;   Mark Joy   ¹ , PhD ;   David Wheeler   ^{3 *} , MD ;   Simon de Lusignan   ^{1 *} , MD

¹ Clinical Informatics and Health Outcomes Research Group, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom

² Clinical Informatics, University of Surrey, Guildford, United Kingdom

³ Department of Renal Medicine, University College London, London, United Kingdom

*these authors contributed equally